Crystalens HD Receives FDA Approval

Newest Version Designed to Further Improve Near Vision

Bausch and Lomb announced that it has received FDA approval to market the Crystalens HD in the United States. The Crystalens accommodating lens (IOL) was first introduced by the FDA in November 2003. The new Crystalens HD is the fourth generation of the only FDA accommodating lens.

The enhanced optic of the Crystalens HD provides an increased depth of focus which is designed to improve near vision without compromising intermediate or distance vision. The HD lens does this without inducing undesirable dysphotopsia or night vision symptoms.

Dr. Jonathan Davidorf was one of the first surgeons in the Los Angeles area to implant the Crystalens. “We have found that, for the right patient, the results have been outstanding. Most Crystalens patients can see to drive, read newspapers and books and use the computer without glasses,” Dr. Davidorf said. “With the new Crystalens HD, we anticipate that the ability to read without glasses will be further improved.
Schedule a Consultation

HomeContact UsLatest NewsVision CorrectionCataract SurgeryCosmetic SurgeryOther ServicesOur DoctorsSite MapGlossary